Your browser doesn't support javascript.
loading
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto, Tadashi; Yamazaki, Fumito; Nakano, Yoshiko; Tamura, Chieko; Tashiro, Shimon; Hattori, Hiroyoshi; Nakagawara, Akira; Tsunematsu, Yukiko.
Afiliação
  • Kumamoto T; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan. tkumamot@ncc.go.jp.
  • Yamazaki F; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Nakano Y; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Tamura C; Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
  • Tashiro S; Medical Information and Genetic Counseling Division, FMC Tokyo Clinic, Tokyo, Japan.
  • Hattori H; Department of Sociology, Graduate School of Arts and Letters, Tohoku University, Sendai, Japan.
  • Nakagawara A; Department of Clinical Genetics, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Tsunematsu Y; Saga International Heavy Ion Cancer Radiation Therapy Center, Saga, Japan.
Int J Clin Oncol ; 26(12): 2161-2178, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34633580

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Síndrome de Li-Fraumeni Tipo de estudo: Guideline Limite: Female / Humans / Male Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Síndrome de Li-Fraumeni Tipo de estudo: Guideline Limite: Female / Humans / Male Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão